BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 28941300)

  • 1. Chagas disease and liver transplantation: Experience in Argentina using real-time quantitative PCR for early detection and treatment.
    Balderramo D; Bonisconti F; Alcaraz A; Giordano E; Sánchez A; Barrabino M; Caeiro JP; Alvarellos T; Maraschio M
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28941300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parasitemia Levels in Trypanosoma cruzi Infection in Spain, an Area Where the Disease Is Not Endemic: Trends by Different Molecular Approaches.
    Flores-Chavez MD; Abras A; Ballart C; Ibáñez-Perez I; Perez-Gordillo P; Gállego M; Muñoz C; Moure Z; Sulleiro E; Nieto J; García Diez E; Simón L; Cruz I; Picado A
    Microbiol Spectr; 2022 Oct; 10(5):e0262822. PubMed ID: 36190410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial.
    Moreira OC; Ramírez JD; Velázquez E; Melo MF; Lima-Ferreira C; Guhl F; Sosa-Estani S; Marin-Neto JA; Morillo CA; Britto C
    Acta Trop; 2013 Jan; 125(1):23-31. PubMed ID: 22982466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of meaningful levels of Trypanosoma cruzi in platelet concentrates from seropositive blood donors.
    Cancino-Faure B; Fisa R; Riera C; Bula I; Girona-Llobera E; Jimenez-Marco T
    Transfusion; 2015 Jun; 55(6):1249-55. PubMed ID: 25683267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV and Chagas Disease: An Evaluation of the Use of Real-Time Quantitative Polymerase Chain Reaction to Measure Levels of Trypanosoma cruzi Parasitemia in HIV Patients in Cochabamba, Bolivia.
    Reimer-McAtee MJ; Mejia C; Clark T; Terle J; Pajuelo MJ; Cabeza J; Lora MH; Valencia E; Castro R; Lozano D; Bern C; Torrico F; Gilman RH
    Am J Trop Med Hyg; 2021 Aug; 105(3):643-650. PubMed ID: 34398818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
    Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
    PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients.
    Castro-Sesquen YE; Gilman RH; Mejia C; Clark DE; Choi J; Reimer-McAtee MJ; Castro R; Valencia-Ayala E; Flores J; Bowman N; Castillo-Neyra R; Torrico F; Liotta L; Bern C; Luchini A;
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004407. PubMed ID: 26919324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Trypanosoma cruzi and Treatment Monitoring by PCR from Dried Blood Spot Samples in Children.
    Sánchez AG; Alvarellos E; Kohout I; Rodriguez Schulz DG; Cordeiro E; Caeiro JP; Alvarellos T
    Rev Fac Cien Med Univ Nac Cordoba; 2016; 73(3):176-180. PubMed ID: 27805554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of Trypanosoma cruzi by heart transplantation.
    Kun H; Moore A; Mascola L; Steurer F; Lawrence G; Kubak B; Radhakrishna S; Leiby D; Herron R; Mone T; Hunter R; Kuehnert M;
    Clin Infect Dis; 2009 Jun; 48(11):1534-40. PubMed ID: 19400748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation.
    Besuschio SA; Picado A; Muñoz-Calderón A; Wehrendt DP; Fernández M; Benatar A; Diaz-Bello Z; Irurtia C; Cruz I; Ndung'u JM; Cafferata ML; Montenegro G; Sosa Estani S; Lucero RH; Alarcón de Noya B; Longhi SA; Schijman AG
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008402. PubMed ID: 32797041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosoma cruzi load in synanthropic rodents from rural areas in Chile.
    Yefi-Quinteros E; Muñoz-San Martín C; Bacigalupo A; Correa JP; Cattan PE
    Parasit Vectors; 2018 Mar; 11(1):171. PubMed ID: 29530074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the parasite load and molecular diversity of Trypanosoma cruzi in patients with chronic Chagas disease from different regions of Brazil.
    Rodrigues-Dos-Santos Í; Melo MF; de Castro L; Hasslocher-Moreno AM; do Brasil PEAA; Silvestre de Sousa A; Britto C; Moreira OC
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006939. PubMed ID: 30418976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
    Fernández MC; González Cappa SM; Solana ME
    Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV.
    Gruendling AP; Massago M; Teston AP; Monteiro WM; Kaneshima EN; Araújo SM; Gomes ML; Barbosa Md; Toledo MJ
    Am J Trop Med Hyg; 2015 Jun; 92(6):1178-89. PubMed ID: 25940197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection.
    Calvet CM; Choi JY; Thomas D; Suzuki B; Hirata K; Lostracco-Johnson S; de Mesquita LB; Nogueira A; Meuser-Batista M; Silva TA; Siqueira-Neto JL; Roush WR; de Souza Pereira MC; McKerrow JH; Podust LM
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006132. PubMed ID: 29281643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCR monitoring of parasitemia during drug treatment for canine Chagas disease.
    Zao CL; Yang YC; Tomanek L; Cooke A; Berger R; Chien LC; Madigan R
    J Vet Diagn Invest; 2019 Sep; 31(5):742-746. PubMed ID: 31378166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial and satellite real time-PCR for detecting T. cruzi DTU II strain in blood and organs of experimentally infected mice presenting different levels of parasite load.
    Ferreira Filho JCR; Braz LMA; Andrino MLA; Yamamoto L; Kanunfre KA; Okay TS
    Exp Parasitol; 2019 May; 200():13-15. PubMed ID: 30904696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of congenital Trypanosoma cruzi infection: A serologic test using Shed Acute Phase Antigen (SAPA) in mother-child binomial samples.
    Volta BJ; Russomando G; Bustos PL; Scollo K; De Rissio AM; Sánchez Z; Cardoni RL; Bua J
    Acta Trop; 2015 Jul; 147():31-7. PubMed ID: 25847262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia.
    Bianchi F; Cucunubá Z; Guhl F; González NL; Freilij H; Nicholls RS; Ramírez JD; Montilla M; Flórez AC; Rosas F; Saavedra V; Silva N
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003465. PubMed ID: 25723465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection.
    Freitas VLT; Novaes CTG; Sartori AMC; Carvalho NB; Silva SCVD; Nakanishi ÉS; Salvador F; Castro CN; Bezerra RC; Westphalen EVN; Oliveira CMR; Busser FD; Ho YL; Buccheri R; Bonilla C; Shikanai-Yasuda MA
    PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011961. PubMed ID: 38408095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.